Focus:
- Protection of transplant patients, immune tolerance
Target:
- Viral-associated malignancies
- Graft infections
- Graft rejection
- High added value niche indications
- Strong medical need
Objectives:
- generate strong and immediate immunity
- induce tolerance to graft
- Active and passive therapy
Strategy:
- develop specific product/adjuvant combinations together with specific administration regimens